摘要
目的 评价乙肝免疫球蛋白阻断乙肝母婴传播的效果。方法 2004年1月~2007年1月选择梅州城区HBsAg阳性孕期从未注射乙肝免疫球蛋白(HBIG)的孕妇所生的婴儿168例,116例婴儿为观察组,注射乙肝免疫球蛋白联合10μg乙肝疫苗;52例婴儿为对照组,常规接种5μg乙肝疫苗。在12个月龄时进行乙肝病毒血清学检测。结果观察组婴儿HBsAg阳性控制率(94.83%)明显高于对照组(67.31%),无效率(5.17%)明显低于对照组(32.69%),两组的差异有显著性意义(P〈0.01)。结论 乙肝免疫球蛋白阻断母婴乙型肝炎病毒的传播具有显著效果。
Objective To evaluate the protective efficacy in preventing mother-toinfant transmission of Hepatitis B Virus (HBV) of Hepatitis B immune globulin (HBIG) Methods We selected 168 cases infants whose HBsAg positive mothers had never HBIG inoculated during: pregnancy between January 2004 to January 2007,116 cases were observer group, inoculated by HBIG combine 10 μg Hepatitis B vaccine (Hep B).52 cases were control group, inoculated by 5 μg Hep B singte. Blood serum was collected and HBV markers was tested at 12-month-old. Results In observer group, the HBsAg positive rate was 5.17% and the protective rate was 94.83%. In Control group, the HBsAg positive rate was 32,69% and the protective rate was 67.37%. There was significant difference between two groups (P〈0. 01).Conclusions The protective efficacy in preventing mother-toinfant transmission of HBIG was significant.
出处
《国际医药卫生导报》
2008年第3期113-115,共3页
International Medicine and Health Guidance News
关键词
乙肝免疫球蛋白
母婴传播
乙肝疫苗
乙型病毒性肝炎
Hepatitis B immune globulin (HBIG) Mother-to-infant transmission Hepatitis B vaccine(Hep B)Hepatitis B